Cancer Medicines & Diagnostic Tools

Own the cancer-care chain from commercial oncology medicines to tumor profiling and laboratory tools, rather than a broad healthcare or biologics basket. Drug-franchise renewal and increasingly individualized treatment create complementary opportunities for medicine developers and diagnostic providers. The basket combines established cash-generating businesses with specialized testing companies, while retaining exposure to clinical, reimbursement and execution risks. Launch basket (equal weight): MRK, ABBV, AMGN, LLY, TMO, BMY, REGN, NTRA, GH, TEM Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.